Federica Casiraghi
Overview
Explore the profile of Federica Casiraghi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perico L, Casiraghi F, Benigni A, Remuzzi G
Trends Mol Med
. 2025 Feb;
PMID: 39984382
The ability to engineer immune cells yielded a transformative era in oncology. Early clinical trials demonstrated the efficacy of chimeric antigen receptor (CAR) T cells in resetting the immune system,...
2.
Perico L, Casiraghi F, Sonego F, Todeschini M, Corna D, Cerullo D, et al.
Front Immunol
. 2025 Jan;
15():1543066.
PMID: 39850882
[This corrects the article DOI: 10.3389/fimmu.2024.1335998.].
3.
Holler S, Casiraghi F, Hanczyc M
ACS Omega
. 2024 Dec;
9(50):49316-49322.
PMID: 39713690
Dynamic soft matter systems composed of functionalized vesicles and liposomes are typically produced and then manipulated through external means, including the addition of exogenous molecules. In biology, natural cells possess...
4.
Perico L, Casiraghi F, Sonego F, Todeschini M, Corna D, Cerullo D, et al.
Front Immunol
. 2024 Mar;
15:1335998.
PMID: 38469301
Introduction: In autoimmune diseases, autoreactive B cells comprise only the 0.1-0.5% of total circulating B cells. However, current first-line treatments rely on non-specific and general suppression of the immune system,...
5.
Perico N, Griffin M, Casiraghi F, Remuzzi G
J Am Soc Nephrol
. 2023 Dec;
34(12):2052-2053.
PMID: 38039090
No abstract available.
6.
Salfi G, Casiraghi F, Remuzzi G
Front Immunol
. 2023 Oct;
14:1247606.
PMID: 37795085
The pathogenetic mechanisms underlying the onset and the post-transplant recurrence of primary focal segmental glomerulosclerosis (FSGS) are complex and remain yet to be fully elucidated. However, a growing body of...
7.
Holler S, Bartlett S, Loffler R, Casiraghi F, Diaz C, Cartwright J, et al.
Proc Natl Acad Sci U S A
. 2023 Aug;
120(33):e2300491120.
PMID: 37561785
Alkaline hydrothermal vents have become a candidate setting for the origins of life on Earth and beyond. This is due to several key features including the presence of gradients of...
8.
Vivarelli M, Colucci M, Algeri M, Zotta F, Emma F, LErario I, et al.
JCI Insight
. 2023 Aug;
8(18).
PMID: 37561590
BACKGROUNDSevere forms of idiopathic nephrotic syndrome (INS) require prolonged immunosuppressive therapies and repeated courses of high-dose glucocorticoids. Mesenchymal stromal cells (MSCs) have promising immunomodulatory properties that may be employed therapeutically...
9.
Perico N, Remuzzi G, Griffin M, Cockwell P, Maxwell A, Casiraghi F, et al.
J Am Soc Nephrol
. 2023 Aug;
34(10):1733-1751.
PMID: 37560967
Significance Statement: Mesenchymal stromal cells (MSCs) may offer a novel therapy for diabetic kidney disease (DKD), although clinical translation of this approach has been limited. The authors present findings from...
10.
Casiraghi F, Perico N, Remuzzi G
Front Immunol
. 2023 Aug;
14:1250624.
PMID: 37554325
No abstract available.